Evidence map›Paper›PMID 35095438›Full record

ReviewFrontiers in behavioral neuroscience2021

Zebrafish as a Useful Tool in the Research of Natural Products With Potential Anxiolytic Effects.

Jonathan Cueto-Escobedo, León Jesús German-Ponciano, Gabriel Guillén-Ruiz, Cesar Soria-Fregozo, Emma Virginia Herrera-Huerta

Abstract readReview
In one paragraph

Review in Frontiers in behavioral neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. International journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Chronic Administration ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Analysis of the underlying mechanism ofPharmaceutical science advances · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jonathan Cueto-EscobedoDepartamento de Investigación Clínica y Traslacional, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Mexico.
León Jesús German-PoncianoLaboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa, Mexico.
Gabriel Guillén-RuizInvestigador por México, Consejo Nacional de Ciencia y Tecnología (CONACyT) - Instituto de Neuroetología, Universidad Veracruzana, Xalapa, Mexico.
Cesar Soria-FregozoLaboratorio Ciencias Biomédicas/Área Histología y Psicobiología, Departamento de Ciencias de la Tierra y de la Vida, Centro Universitario de Los Lagos, Universidad de Guadalajara, Lagos de Moreno, Mexico.
Emma Virginia Herrera-HuertaFacultad de Ciencias Químicas, Universidad Veracruzana, Orizaba, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zebrafish (

Indexed as

anxietybehavioral pharmacologyplant metabolitestranslational researchzebrafish

Identifiers

PMID35095438
PMCPMC8789748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.